Thank you for joining the CodeX team on March 16, 2023 for our update on the progress within GenomeX.

Attendees: 106 total: 97 external, 9 CodeX

  • Association for Molecular Pathology
  • CancerLinQ,  American Society of Clinical Oncology
  • Beth Israel Deaconess Medical Center
  • Caris Life Sciences 
  • Carradora Health
  • CDISC
  • Cancer Informatics for Cancer Centers  
  • Children's Hospital LA
  • Children's Hospital of Philadelphia
  • Clinical Architecture
  • College of American Pathologists
  • Concert Genetics
  • Duke University
  • Elimu Informatics
  • Elsevier
  • Emory University
  • Epic
  • eviCore/Evernorth
  • Flatiron Health
  • Foundation Medicine
  • GenomOncology
  • Humanized Health Consulting  / Elimu
  • Kaiser Permanente
  • Invitae
  • Leap of Faith Technologies,  Inc.
  • M2GEN
  • National Health System (UK)
  • Northwestern University
  • ONC
  • OncoChain Solutions
  • Oracle / Cerner
  • Pfizer
  • Philips Healthcare
  • Q2 Solutions
  • Roche Information Solutions
  • Synerio
  • Tempus
  • TISLab
  • Vanderbilt University Medical Center
  • University of Wisconsin–Madison

Resources:

Today's slides: 2023-03-16 GenomeX Community Call.pdf

Today's recording: GenomeX Community Meeting 03-16-2023 Recording


GenomeX Community Meeting

Facilitator: Arthur Hermann (arthur.hermann@kp.org)

GenomeX Coordinator: Mallory Carellas (mcarellas@mitre.org)

Data Exchange Coordinator: Michelle Casagni (mcasagni@mitre.org)

Operations Coordinator: James Patterson (jpatterson@mitre.org)


Meeting Norms

  • Please add your name and organization in the chat. 
  • When speaking, please start with your name and organization.

Agenda

  1. GenomeX Overview  (5 min)
  2. Data Exchange Use Case
    • Overview and Status of MVP (10 min)
    • Data Exchange Use Case Sub-Work Groups (5 min)
  3. Operations Use Case 
    • Introduction (5 min)
    • Molecular Tumor Board Application (10 min)
    • Rare Disease Application (5 min)
    • Reference Implementation Updates (5 min)
  4. Wrap-up and Open for Q&A 



  • No labels